Trials / Completed
CompletedNCT00775658
Olopatadine Eye Drops and Allergy Skin Testing
Effect of Olopatadine Hydrochloride 0.2% Ophthalmic Solution on Epicutaneous Skin Prick Testing With Histamine and Saline
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Vanderbilt University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Use of olopatadine ophthalmic solution (eye drops) will decrease allergy skin test reactivity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | olopatadine | olopatadine 0.2% opthalmic solution 1 drop into each eye at the same time each day |
| DRUG | placebo | placebo, normal saline opthalmic solution 1 drop into each eye at the same time each day |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2008-10-20
- Last updated
- 2017-07-12
- Results posted
- 2017-07-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00775658. Inclusion in this directory is not an endorsement.